7 JCI-accredited hospitals · 45+ hospitals & clinics · 90+ countries served · 24/7 multilingual support
Skin & Hair

How Atopic Dermatitis Treatment Escalates: Barrier Repair, Topicals, Phototherapy and Beyond

27 min read
How Atopic Dermatitis Treatment Escalates: Barrier Repair, Topicals, Phototherapy and Beyond

Key Takeaways

  • Atopic dermatitis involves both a leaky skin barrier, often linked to altered filaggrin genes, and an over-active immune response driven by interleukin-4 and interleukin-13.
  • Treatment steps accumulate rather than replace each other: a person on a biologic injection is still expected to moisturize daily and treat flares topically.
  • Topical corticosteroid potency is matched to skin thickness, with milder preparations on the face and folds and stronger ones on thick, lichenified areas, per NHS guidance.
  • Non-steroid creams, including calcineurin inhibitors, PDE4 inhibitors and topical JAK inhibitors, do not thin the skin and are often chosen for eyelids, lips and skin folds.
  • Phototherapy with narrowband UVB works gradually over a supervised course of several weeks, is generally avoided in infants and adds to lifetime cumulative UV exposure.
  • Infection, contact allergy and mimics such as scabies or fungal infection are common reasons eczema appears treatment-resistant and are checked before escalating.
Quick Answer

Atopic dermatitis treatment steps move up a ladder: daily barrier repair with moisturizers and gentle bathing first; then anti-inflammatory creams such as topical corticosteroids or calcineurin inhibitors for flares; then intensified measures like wet wraps; then phototherapy; and, for persistent moderate-to-severe disease, systemic medicines including biologics or JAK inhibitors. Each step is added, not swapped, and the pace is set by the treating clinician.

The jar sits on the bathroom shelf, half used, next to a tube with the label worn off. You have tried three moisturizers this year, two creams from the pharmacy and one from a friend, and the itch still wakes you at two in the morning. Somewhere between the first red patch on the inside of an elbow and the fourth sleepless week, a quiet question forms: what comes next, and how do you know when it is time?

That question has a clearer answer than most people expect. Atopic dermatitis treatment steps are not a guessing game; they follow a well-described ladder that dermatology guidelines have refined over decades. The rungs are added one on top of another, from barrier repair to prescription creams to light therapy and, for the small group who need it, medicines that work on the immune system itself.

This article walks that ladder rung by rung, explains the mechanism behind each step, and is honest about what the evidence shows and where it runs thin.

What is actually happening in atopic dermatitis skin?

Atopic dermatitis, the most common form of eczema, is a long-term inflammatory skin condition that produces dry, itchy, inflamed patches that come and go. Two things are going wrong at once, and every treatment on the ladder targets one or both of them.

The first problem is the skin barrier. The outermost layer of skin works like a brick wall: flattened cells are the bricks, and a mortar of fats (lipids) holds them together and keeps water in. In many people with atopic dermatitis, a gene that makes a barrier protein called filaggrin is altered, so the wall is leaky from birth. Water escapes, the skin dries and cracks, and irritants, allergens and microbes slip through. The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) describes this combination of genetic barrier weakness and environmental triggers as the core of the disease.

The second problem is the immune response. Once the barrier is breached, the immune system over-reacts with a particular set of chemical messengers, especially interleukin-4 and interleukin-13, which drive redness, swelling and the relentless itch. Scratching then tears the wall further, which invites more inflammation. Dermatologists call this the itch-scratch cycle, and breaking it is the whole point of treatment.

Knowing this makes the ladder easier to understand. Moisturizers patch the wall. Anti-inflammatory creams calm the local immune reaction. Phototherapy dampens immune cells in the skin more broadly. Systemic medicines block specific messengers throughout the body. Nothing on the ladder changes the underlying genetics, which is why management is long-term rather than a one-off fix. The NHS notes that the condition often improves over time in children, with Mayo Clinic adding that it most often begins before age five and may persist into adolescence and adulthood.

Why atopic dermatitis treatment steps follow a ladder rather than a single prescription

People often arrive at a dermatology appointment hoping for the one cream that will settle everything. The honest answer is that the condition is managed in layers, and the lowest layers never get removed as you climb.

Doctor consulting patient about skin condition: Why atopic dermatitis treatment steps follow a ladder rather than a single p

A stepped approach does three useful things. It matches the strength of treatment to the severity of disease, so that mild, patchy eczema is not treated with medicines designed for widespread inflammation. It keeps the foundations in place: a person starting a biologic injection is still expected to moisturize daily, because the barrier defect is permanent. And it gives the treating team a structured way to judge whether a step has genuinely failed before moving on, rather than reacting to one bad week.

The ladder, as described across NHS, Mayo Clinic and NIAMS guidance, looks like this in plain language:

  • Barrier repair and trigger avoidance, used by everyone, every day.
  • Topical anti-inflammatory treatments for flares: corticosteroid creams or ointments and, where appropriate, non-steroid alternatives.
  • Intensified topical measures such as wet wraps or medicated bandages, usually under supervision.
  • Phototherapy with controlled ultraviolet light.
  • Systemic treatment: older immunosuppressant tablets, newer biologic injections or oral JAK inhibitors.

Severity is judged not just by how the skin looks but by how much the condition intrudes on sleep, work, school and mood. Someone with a small patch that keeps them awake every night may be offered a higher rung than someone with a larger but painless area. That judgment belongs to the prescribing clinician, who weighs the person’s age, overall health, how long they have been on the current step and whether it has been used consistently.

One more principle matters: before escalating, clinicians usually check that the current step has been used correctly. A surprising share of apparent treatment failure is really under-treatment, a point we return to later.

Step one: what do I use for atopic dermatitis every day? Barrier repair explained

Ask any dermatologist what matters most, and the answer is unglamorous: moisturize, generously and often, even when the skin looks fine. Emollients, the clinical term for medical moisturizers, are the one treatment on the ladder that every person with atopic dermatitis uses for life.

An emollient works in two ways. Occlusive ingredients such as petrolatum or mineral oil form a film that slows water loss through the leaky barrier. Humectant ingredients such as glycerin or urea draw water into the outer skin layers. Ointments contain the most oil and the least water, so they seal best but feel greasy; creams and lotions are lighter and easier to spread over large areas but evaporate faster. The NHS advises choosing the format you will actually use consistently, and many people keep an ointment for night and a cream for daytime.

Bathing habits are part of this step, not separate from it. Mayo Clinic recommends shorter, lukewarm baths or showers rather than long hot ones, which strip lipids, and patting rather than rubbing the skin dry. The important move is applying moisturizer within a few minutes of getting out, while the skin is still slightly damp, to trap that water in place.

Fragrance-free products matter because perfume ingredients are among the most common causes of contact allergy on already-damaged skin. Soap substitutes, which clean without the detergent action that dissolves the barrier’s mortar, are recommended by the NHS in place of ordinary soap and bubble bath.

Trigger management rounds out the foundation. Common triggers listed by MedlinePlus and NIAMS include wool and rough fabrics, sweat, heat, dry indoor air, harsh detergents, stress and, in some people, specific foods or airborne allergens. Not every trigger applies to every person, and strict elimination diets without clinical guidance can do more harm than good, especially in children.

Step two: topical corticosteroids and how flares are usually treated

When a patch flares, moisturizer alone will not settle the inflammation underneath. The next rung is a topical corticosteroid: a cream or ointment containing a synthetic version of cortisol, the body’s own anti-inflammatory hormone, applied directly to the inflamed skin.

Doctor examining patient's arm or hand during consultation: Step two: topical corticosteroids and how flares are usually tre

Mechanism first. Corticosteroids enter skin cells and switch off genes that produce inflammatory messengers while switching on genes that calm the response. Redness fades, swelling drops and, usually within days, the itch eases. Because the drug stays largely in the skin, the body-wide effects seen with steroid tablets are far less of a concern when the cream is used as prescribed.

Topical corticosteroids come in a range of potencies, from mild to very potent. The NHS explains that clinicians choose a potency according to how severe the eczema is and where it sits: thin skin on the face, eyelids and skin folds is treated with milder preparations, while thick, lichenified skin on the hands or shins may need something stronger. The prescribing clinician specifies which product, where and for how long; this article deliberately does not.

A common pattern described by the NHS is to treat a flare until the skin is clear, then stop and return to moisturizers alone. For people whose eczema returns quickly in the same spots, some clinicians prescribe a planned, intermittent maintenance schedule to prevent flares, sometimes called weekend therapy. Whether that is appropriate is an individual decision.

Side effects are real but widely misunderstood. Thinning of the skin, stretch marks and visible small blood vessels can occur with prolonged use of potent products, particularly on delicate areas. Mayo Clinic notes these risks diminish when products are used correctly and for the right duration. Topical steroid withdrawal, a pattern of worsening after stopping long-term use, has been reported but is not yet well characterized in the research literature; it is a reason to follow the prescribed plan, not a reason to avoid the treatment entirely.

Non-steroid topical options: calcineurin inhibitors, PDE4 inhibitors and topical JAK inhibitors

Not every inflamed patch suits a corticosteroid. Eyelids, lips, the neck and skin folds are thin and prone to steroid side effects, and some people need treatment on those areas for months. Three non-steroid classes fill that gap, each with a different mechanism.

Topical calcineurin inhibitors, the generic names tacrolimus and pimecrolimus, block an enzyme called calcineurin that immune T-cells need in order to switch on and release inflammatory messengers. They do not thin the skin, which is why Mayo Clinic and the NHS describe them as options for sensitive sites and for longer-term use. The common early side effect is a burning or stinging sensation that usually settles after the first days of use. They carry a regulatory boxed warning about a theoretical cancer risk; long-term observational studies have not confirmed an increased risk in people using them as directed, which is the kind of uncertain-but-reassuring evidence worth stating plainly.

Topical phosphodiesterase-4 (PDE4) inhibitors, such as crisaborole, block an enzyme inside immune cells that would otherwise amplify inflammatory signaling. They are approved for mild-to-moderate disease and, again, do not cause skin thinning. Stinging on application is the main complaint.

Topical JAK inhibitors, such as ruxolitinib cream, block Janus kinase enzymes, which sit inside cells and relay the signals from messengers like interleukin-4 and interleukin-13. By cutting the relay, the cream reduces both inflammation and itch. Because JAK inhibition can affect immune function, prescribers limit the area of skin treated and the duration of use, and the product carries the same class warnings as oral JAK inhibitors.

None of these replaces a moisturizer. In practice, a clinician may prescribe a corticosteroid for the trunk and limbs, a calcineurin inhibitor for the face, and daily emollient everywhere. Which combination is right, and whether a non-steroid option is worth its typically higher prescribing threshold, is a conversation for the treating team.

Step three: wet wraps, bandages and treating infected eczema

When topical treatment is being used correctly but a flare will not break, the next move is often not a new drug but a new way of delivering the old ones. Wet wrap therapy is the clearest example.

A wet wrap involves applying moisturizer, and where prescribed a topical corticosteroid, to the skin and then covering it with a layer of damp cotton bandage or garment, followed by a dry layer on top. The damp layer cools the skin, which reduces itch; it increases the absorption of the medicine underneath; and it forms a physical barrier against scratching, particularly overnight. The NHS lists medicated bandages and wet wraps among options for more severe or persistent eczema, and Mayo Clinic describes wet dressings as an intensive treatment sometimes used for severe flares.

Because wet wraps increase how much corticosteroid reaches the bloodstream, they are usually started under the supervision of a dermatology nurse or clinician who demonstrates the technique, specifies which areas can be wrapped and sets a time limit. This is one rung where doing it yourself from an online video is a genuinely bad idea.

Infection is the other reason flares stall. Broken eczematous skin is heavily colonized by the bacterium Staphylococcus aureus, which itself drives inflammation. When the skin weeps, crusts yellow, becomes painful or hot, or the person develops a fever, the NHS advises seeing a clinician, because a course of antibiotic treatment may be needed before the eczema will respond to anything else. Diluted bleach baths, which lower the bacterial load on the skin, are described by Mayo Clinic as an option for people with frequent infections; concentration and frequency are set by the clinician, not improvised.

A viral infection called eczema herpeticum, where the cold-sore virus spreads across eczema-damaged skin, is a medical emergency and is covered in the red-flag section below.

Step four: phototherapy for eczema, how it works and what sessions involve

Phototherapy, or light therapy, uses carefully measured doses of ultraviolet light to calm inflammation across large areas of skin. It sits above intensive topical treatment on the ladder and below systemic medicines, and the NHS lists it among treatments a dermatologist may offer when creams and ointments are not enough.

The most widely used form is narrowband ultraviolet B (UVB), a narrow slice of the UV spectrum chosen because it penetrates to the depth where the inflammatory cells sit while limiting the burning wavelengths. UV light reduces the number and activity of immune cells in the skin, lowers the production of inflammatory messengers and may also reduce the bacterial load on the surface. The effect builds gradually rather than switching on at the first session.

In practice, a person attends a hospital or clinic cabinet lined with fluorescent tubes, wears protective goggles and stands in the light for a period that starts at seconds and lengthens over the course. Mayo Clinic notes that phototherapy is generally used for people who do not improve with topical treatment or who flare again quickly after it. Courses run over several weeks, with the exact schedule, number of sessions and dose increases determined by the phototherapy team based on skin type and response.

The trade-offs are practical and biological. Attending sessions several times a week is a real burden for anyone who works or travels. Short-term effects include redness, dryness and, occasionally, a sunburn-like reaction. Long-term, repeated UV exposure causes premature skin aging and raises the risk of skin cancer, which is why Mayo Clinic advises that phototherapy is less commonly used in young children and is avoided in infants, and why clinicians keep records of cumulative exposure.

Phototherapy does not suit everyone, and it is not a permanent solution; benefit often fades in the months after a course ends. For some people it is a bridge during a bad period; for others it is a way to delay or avoid systemic medicine.

Step five and beyond: systemic treatment with immunosuppressants, biologics and JAK inhibitors

For a minority of people, moderate-to-severe atopic dermatitis persists despite everything above. At this point treatment moves inside the body. Three groups of systemic medicine exist, and understanding their mechanisms clarifies why clinicians choose between them.

Conventional immunosuppressants, including ciclosporin, methotrexate, azathioprine and mycophenolate, have been used for decades. They dampen the immune system broadly rather than targeting eczema specifically, which brings effectiveness at the cost of monitoring: regular blood tests to watch kidney and liver function, blood pressure and blood counts. The NHS notes that these are specialist-prescribed and that short courses of oral corticosteroid tablets are sometimes used for severe flares but are not suitable for long-term control because of their side effects.

Biologics are laboratory-made antibodies given by injection under the skin. Dupilumab, the first approved for atopic dermatitis, blocks the shared receptor for interleukin-4 and interleukin-13, the two messengers at the heart of the disease. Tralokinumab and lebrikizumab block interleukin-13 directly. Because they target one pathway rather than the whole immune system, routine blood monitoring is generally not required. Eye inflammation (conjunctivitis) is the most recognized class side effect, along with injection-site reactions. Mayo Clinic describes these as options for people with moderate-to-severe disease not controlled by other treatments.

Oral JAK inhibitors, such as upadacitinib and abrocitinib, are tablets that block the Janus kinase enzymes relaying signals inside cells. They tend to act on itch faster than biologics, but they carry regulatory warnings covering serious infections, blood clots, cardiovascular events and certain cancers, observed mainly in older people with other risk factors in trials of related drugs. Prescribers screen for those risks and arrange monitoring before starting.

Every systemic option involves a candid risk-benefit conversation. None is started lightly, none is stopped abruptly without medical advice, and the choice between them depends on age, other conditions, pregnancy plans, prior treatment history and personal preference about injections versus tablets.

The eczema treatment ladder at a glance: comparison table

The table below summarizes the rungs described above. It is a map, not a prescription: where a person sits on the ladder, and when they move, is decided by the treating team.

Step Main treatments How it works Usually for Key trade-offs
1. Barrier repair Emollients, soap substitutes, trigger avoidance Seals in water, reduces irritant entry Everyone, every day, lifelong Time and consistency; greasy textures
2. Topical anti-inflammatories Topical corticosteroids; calcineurin, PDE4 or JAK inhibitor creams Switches off local inflammatory signaling Active flares; sensitive sites for non-steroids Skin thinning if misused; stinging with non-steroids
3. Intensified topical care Wet wraps, medicated bandages, infection treatment Boosts absorption, cools itch, blocks scratching, clears bacteria Flares not settling with correct topical use Needs supervision; increases steroid absorption
4. Phototherapy Narrowband UVB Reduces immune cell activity in skin Widespread disease not controlled by creams Frequent visits; cumulative UV risk; not for infants
5. Systemic therapy Immunosuppressants, biologics, oral JAK inhibitors Blocks immune messengers or enzymes body-wide Moderate-to-severe disease despite steps 1–4 Monitoring, infection risk, class-specific warnings

Two points are easy to miss when reading a table like this. First, the steps accumulate: a person on a biologic is still on steps one and two. Second, the ladder is not strictly one-directional. Many people climb during a bad winter and come back down when the skin settles, and clinicians regularly review whether a higher rung is still needed.

The sources behind each row are the NHS treatment guidance, Mayo Clinic’s diagnosis and treatment overview and the NIAMS patient information, all linked in the references.

Who is usually offered the next atopic dermatitis treatment step, and who is asked to wait

Escalation is a decision, and clinicians make it with a fairly consistent set of criteria. Knowing them helps you have a more productive conversation.

Moving up is usually considered when the current step has been used consistently and correctly for an adequate period and the eczema is still interfering with daily life. Interference is measured in sleep lost, days of school or work missed, pain, visible distress, and the proportion of body surface involved. Frequent skin infections and repeated need for rescue steroid courses are also signals that the current level is not holding.

People commonly asked to wait before escalating fall into a few groups. The first is anyone whose current step has not really been given a fair trial: a steroid cream applied for two days and abandoned, or a moisturizer used only when the skin feels dry, is not a failed treatment. The second is anyone with an untreated complicating factor, most often infection or a contact allergy to an ingredient in a product they are using. A third group is people in whom a mimic has not been ruled out; scabies, fungal infection and contact dermatitis can all look like treatment-resistant eczema.

Age shapes the options. Mayo Clinic notes that phototherapy is generally avoided in infants and used cautiously in young children. Biologics and JAK inhibitors are approved from different minimum ages depending on the product and the regulator, and the NHS directs that systemic treatments are prescribed by specialists. Pregnancy and plans to conceive change the calculus for most systemic medicines and some topicals, which is why clinicians ask early.

Other health conditions matter too. A history of blood clots, cardiovascular disease, serious infection or cancer weighs heavily against oral JAK inhibitors; kidney disease weighs against ciclosporin; eye problems may influence biologic choice. The treating team balances these factors against how badly the eczema is affecting the person, and the final decision, including whether to wait, rests with them.

What the following days and weeks usually look like after stepping up treatment

Timelines vary by step, and most disappointment comes from expecting a faster response than the biology allows. What follows are typical ranges from the cited sources, not promises.

After starting a consistent emollient routine, skin texture often improves within one to two weeks, though the full benefit on flare frequency takes longer and depends on daily use. MedlinePlus and the NHS both frame moisturizing as a continuous habit rather than a course with an end date.

With a topical corticosteroid applied as prescribed, itch frequently eases within days and visible redness settles over one to two weeks for a typical flare, according to the NHS, which also advises continuing until the flare has cleared rather than stopping at the first sign of improvement. Non-steroid creams tend to act a little more slowly and may sting during the first few days.

Phototherapy improves gradually over a course of several weeks, with the NHS and Mayo Clinic both describing it as a specialist-supervised course rather than a single treatment. People often report the first noticeable change midway through, and benefit may continue for a period after the course finishes before gradually waning.

Systemic medicines each have their own tempo. Oral JAK inhibitors commonly reduce itch within the first one to two weeks of treatment. Biologics usually show meaningful improvement over the first four to sixteen weeks, and prescribers typically assess response at around the sixteen-week point before deciding whether to continue; these ranges reflect how the medicines were studied in their approval trials and are summarized in Mayo Clinic’s treatment overview.

What the weeks also look like, for any step, is monitoring. Expect questions about sleep, itch scores and body-surface area at follow-up, and for systemic treatment, blood tests or eye checks on a schedule set by the clinician. Keeping a short daily note of itch, sleep and what was applied makes those appointments far more useful.

What is mostly mistaken for eczema? Red bumps, rashes and look-alikes

A fair number of people climbing the ladder do not have atopic dermatitis at all, or have it alongside something else. When a step fails, a good clinician reconsiders the diagnosis before escalating, and so should you.

Contact dermatitis is the most frequent confusion. It is an inflammatory reaction to something touching the skin, either an irritant such as detergent or an allergen such as nickel, fragrance or a preservative in a cream. It can sit on top of atopic dermatitis, and it is a classic reason eczema seems to resist treatment: the moisturizer itself is the culprit. Patch testing, where small amounts of common allergens are taped to the back for two days, is how clinicians sort this out.

Seborrheic dermatitis produces greasy, yellowish scale on the scalp, eyebrows, sides of the nose and chest, areas rich in oil glands. Psoriasis forms thicker, more sharply bordered plaques with silvery scale, often on the elbows, knees and scalp, and tends to itch less. Fungal infections (tinea) spread outward in a ring with a clearer center and can be made worse by steroid creams. Scabies, an infestation by a tiny mite, causes intense itch that is worse at night, with fine burrows between the fingers and around the wrists; it spreads through households and will not respond to eczema treatment at all.

People searching for the cause of red bumps on the skin are often describing something other than classic eczema. Folliculitis (inflamed hair follicles), keratosis pilaris (rough bumps on the upper arms), insect bites, hives and heat rash are all common answers. Red bumps that are hot, painful, spreading quickly, filled with pus, or accompanied by fever need prompt medical assessment rather than an internet search.

Mayo Clinic and MedlinePlus both stress that diagnosis is clinical, based on the history, the distribution of the rash and examination, sometimes with patch testing or a skin scraping. This article cannot diagnose, and the pattern that looks obvious online is frequently not the one a dermatologist sees.

What people often get wrong about atopic dermatitis treatment steps

Myths cluster around eczema more than around most skin conditions, partly because the disease is visible and partly because it fluctuates, which makes almost any intervention look like it worked. Here are the misunderstandings clinicians correct most often.

“Moisturizer is only for dry days.” The barrier defect is permanent, so the emollient is a daily medicine, not an occasional comfort. Skipping it on good days is one of the commonest reasons flares return.

“Steroid creams are dangerous, so use as little as possible.” Under-treatment is a far bigger practical problem than over-treatment. Applying a thin, hesitant smear for a day or two leaves the inflammation smoldering and often leads to longer total steroid exposure than a proper course would. The NHS guidance is clear: use the prescribed amount, on the prescribed areas, for as long as the flare needs, then stop.

“Stage 1 eczema has a defined look.” People search for what stage one eczema looks like, but atopic dermatitis is not staged the way some diseases are. Clinicians describe acute eczema (red, weepy, sometimes blistered), subacute (red, scaly, drier) and chronic (thickened, leathery, darker or lighter than surrounding skin). These are phases a single patch can move through, not grades of disease progression.

“It is caused by food, so cut out dairy and gluten.” Food allergy coexists with atopic dermatitis in some children, but food is rarely the sole driver, and the NHS warns against restriction diets without specialist advice because of the risk of poor nutrition in a growing child.

“Natural means safer.” Many botanical oils and herbal creams contain fragrance components that are common contact allergens. Coconut oil, olive oil and essential oils have each been linked to contact dermatitis on eczema-prone skin.

“If I reach the biologic step, I can stop the creams.” Systemic treatment sits on top of the foundations, not instead of them.

Questions to ask your care team before moving up a step

A follow-up appointment for eczema is often short, and the questions that matter can be forgotten in the moment. Bringing a written list changes the quality of the conversation. These are the ones clinicians say they wish people asked more often.

  • Which step of the ladder am I on now, and what would need to happen for you to recommend the next one?
  • How do you want me to use the current treatment: which areas, how often, and for how long after the skin looks clear?
  • Could something other than atopic dermatitis be contributing, such as contact allergy, infection or a mimic, and is patch testing or a skin swab worth doing?
  • Are any of the products I am using, including moisturizers and soap substitutes, likely to contain ingredients that irritate or sensitize?
  • What side effects should I watch for with this treatment, and which ones mean I should stop and call rather than wait for the next appointment?
  • If phototherapy is being considered, what would the schedule involve, and how will cumulative exposure be tracked?
  • For systemic options, what monitoring is required, how does the choice between tablets and injections work, and how do my other health conditions or pregnancy plans affect it?
  • How will we measure whether this step is working, and when will we review it?
  • Is there a written action plan I can keep, showing what to do on good days, flare days and infected days?
  • Who do I contact between appointments if things get worse?

Written eczema action plans, similar to asthma plans, are recommended in several national guidelines because they turn a fluctuating condition into a set of clear instructions. Ask for one if it has not been offered.

Finally, ask what the clinician considers the single most important thing to get right at your current step. The answer is usually simpler than people expect, and it is usually about consistency rather than about finding a new product.

When to call your doctor: red-flag signs that should not wait

Most eczema care happens at home, and most flares settle with the plan already in place. A small number of situations need same-day or emergency assessment, and recognizing them is part of safe self-management.

Seek urgent care, which may mean an emergency department, if you or your child develops clusters of small, uniform blisters or punched-out, crusted sores spreading rapidly across eczema-affected skin, especially with fever, feeling very unwell or swollen glands. The NHS describes this pattern as possible eczema herpeticum, an infection with the herpes simplex virus that can become serious quickly and needs antiviral treatment. Blisters near the eyes are a particular concern.

Contact your doctor the same day if the skin becomes hot, swollen and painful, weeps fluid, develops yellow or honey-colored crusts, or if a flare is accompanied by fever. These suggest a bacterial infection that usually needs treatment before the eczema will respond. Red streaks spreading from a patch, or a rapidly enlarging area of redness, should be assessed promptly.

Call for an earlier-than-planned review, rather than waiting, if a flare is not improving after using the prescribed treatment correctly for the period your clinician specified; if itch is destroying sleep night after night; if a child is unusually irritable, refusing to eat or losing weight; if widespread redness covers most of the body; or if you notice side effects such as unexpected skin thinning, new eye symptoms on a biologic, or signs of infection on any systemic medicine.

Mental health belongs on this list. Persistent itch and visible skin disease are strongly linked with anxiety, low mood and sleep disruption, and clinicians treat these as part of the condition rather than a side issue. Say so if you are struggling.

In every case above, the decision about what to change, start or stop belongs to the clinician who knows your history. Do not stop a prescribed systemic medicine on your own, even if you suspect it is causing a problem; call and ask.

Frequently asked questions

What do I use for atopic dermatitis on a daily basis?

A fragrance-free emollient applied generously and often, plus a soap substitute instead of ordinary soap, is the daily foundation for everyone with atopic dermatitis. Ointments seal best; creams spread more easily. Apply within minutes of bathing while the skin is damp. Anti-inflammatory creams are added for flares on a clinician’s advice, but the moisturizer continues every day regardless of how the skin looks.

What is the eczema treatment ladder, in simple terms?

The eczema treatment ladder is a stepped sequence: barrier repair with moisturizers first, then topical anti-inflammatory creams for flares, then intensified measures such as wet wraps, then phototherapy, then systemic medicines including biologics or JAK inhibitors for persistent moderate-to-severe disease. Each step is added on top of the previous ones, and the treating clinician decides when a step has been adequately tried before moving up.

What is mostly mistaken for eczema?

Contact dermatitis is the most common look-alike, often triggered by fragrance or preservatives in a cream being used to treat the eczema. Seborrheic dermatitis, psoriasis, fungal infections and scabies are also regularly confused with atopic dermatitis. Because several of these worsen with steroid creams or need entirely different treatment, clinicians reconsider the diagnosis, sometimes with patch testing or a skin scraping, when eczema seems resistant.

What does stage 1 eczema look like?

Atopic dermatitis is not formally staged. Clinicians instead describe phases of a patch: acute eczema is red, weepy and sometimes blistered; subacute eczema is red, dry and scaly; chronic eczema is thickened, leathery and may be darker or lighter than surrounding skin. A single area can move through all three. Early eczema in infants often appears on the cheeks and scalp; in older children and adults, the elbow and knee creases.

What could be causing red bumps on my skin if it is not eczema?

Red bumps have many causes beyond eczema, including folliculitis (inflamed hair follicles), keratosis pilaris, insect bites, hives, heat rash, acne and viral rashes. Bumps that are hot, painful, pus-filled, spreading quickly or accompanied by fever need prompt medical assessment. A clinician diagnoses by examining the distribution, texture and history of the rash; an online image search is not a substitute.

How does phototherapy for eczema actually work?

Phototherapy for eczema exposes the skin to measured doses of narrowband ultraviolet B light in a supervised cabinet. The light reduces the number and activity of inflammatory immune cells in the skin and may lower surface bacteria. Benefit builds gradually over a course of several weeks. It is used when creams are not enough, is avoided in infants and adds to cumulative lifetime UV exposure, so sessions are tracked.

How long does it take for a topical steroid to work on an eczema flare?

Itch often eases within days and redness typically settles over one to two weeks for a routine flare when a topical corticosteroid is applied as prescribed, according to NHS guidance. Stopping at the first sign of improvement often lets the flare return. The clinician sets the potency, the areas and the duration; if a flare is not responding within the expected window, infection or a mimic may be the reason.

Are biologics or JAK inhibitors safe for long-term atopic dermatitis treatment?

Both are approved for ongoing use in moderate-to-severe atopic dermatitis, with different safety profiles. Biologics such as dupilumab target one immune pathway and generally need no routine blood tests, with eye inflammation the best-known side effect. Oral JAK inhibitors act faster on itch but carry warnings about infection, blood clots and cardiovascular events, so prescribers screen and monitor. Suitability is an individual decision with the treating team.

Can atopic dermatitis go away on its own?

In many children the condition improves substantially or settles by adolescence, though the skin often stays dry and sensitive, and the condition can return in adulthood. Mayo Clinic notes it most often begins before age five and may persist. Adults with persistent disease usually need long-term management rather than expecting it to resolve. Consistent barrier care reduces flares at every age.

Do wet wraps help severe eczema, and can I do them at home?

Wet wraps can help break a stubborn flare by cooling itch, improving absorption of topical treatment and preventing scratching overnight. They are usually started under the guidance of a dermatology nurse or clinician who demonstrates the technique and specifies which areas and how long, because wrapping increases how much corticosteroid is absorbed. Once taught, many families continue them at home within the limits set by the team.

References

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.

Dr. Şule Eren
Dr. Şule Eren, MD
Author
View profile →
Published November 20, 2026
Keep Reading

More from the Blog

We’re With You at Every Step

How can we help you today?

We value your privacy We use essential cookies to run this site and, with your consent, analytics cookies to understand how it is used and improve it. You can accept, reject, or choose what to allow. See our Cookie Policy.